AzTrials
AzTrials

Idiopathic EdemaNCT05185193

Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency

A study testing radiofrequency in people with Idiopathic Edema, run by Pusan National University Yangsan Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to verify the efficacy and safety of the radiofrequency stimulation compared to the sham stimulation in reducing lower extremity edema in adult women with idiopathic edema. Read more about this study

Who is it for?
Ages 19 to 72 years, women onlyHealthy volunteers can take part
Conditions the study is for
Idiopathic Edema
What is being tested?
radiofrequency
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
15 participants
Where
1 siteSouth Korea
Study dates
30 Jun 2020to 21 May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 72 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Women between the ages of 19 and 72
  • Those who are not likely to menstruate during the trial treatment period (3 days) (females within 8 to 18 days after the onset of menstruation)
  • Those who meet the diagnostic criteria for idiopathic edema (McKendry criteria score of 15 or higher)
  • Those who show a weight change of 1.4 kg or more between morning and night measurements
  • Those who have a difference of 1cm or more from the ankle or 2cm or more from the calf when measuring the circumference in the morning and evening
  • Those who voluntarily agree to participate in this clinical trial and sign the consent form

Who cannot join

  • In the case of using a heart rate control device such as a metallic substance in the human body
  • During menstruation or if there is a possibility of pregnancy
  • If you have heart disease
  • If you have liver or kidney disease
  • If there is bleeding or internal bleeding from wounds or surgery
  • For hypertensive patients
Show all 9Show fewer
  • For epilepsy patients
  • If you are taking weight loss or health-related drugs/health functional foods
  • In the case where it is judged by the principal investigator that participation in this study is not appropriate

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Pusan national university Yangsan Hospital

    Gyeongsang, Yangsan, 50610

Other trials in South Korea

About this study

Official title: Efficacy and Safety Evaluation of Changes in Lower Extremity Edema of Radiofrequency in Adult Women With Idiopathic Edema: Blinded, Cross-over, Pilot Study

The purpose of this study is to verify the efficacy and safety of the radiofrequency stimulation compared to the sham stimulation in reducing lower extremity edema in adult women with idiopathic edema.

Read the detailed description

In this study, based on the characteristics of radiofrequency, it was hypothesized that radiofrequency could have an effect on the reduction of lower extremity edema and prevention of fatigue. The occurrence of edema is interpreted as a problem that blood circulation is not smooth due to increased inflow of body fluid, and therefore the degree of edema is also used as an indicator of blood circulation.

Therefore, in this study, based on the principle that radiofrequency promotes phosphorylation and blood circulation, the purpose of this study is to investigate whether radiofrequency treatment is effective in reducing edema of the lower extremities and changing body heat in the lower extremities compared to the gastric stimulation device through exploratory research.

Being tested
radiofrequency, sham stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • radiofrequencyDevice

    Also called high frequency

    Radiofrequency of 9.50v, 218.5mA and 2.076W is applied once a day for 30 minutes, a total of 3 times

  • sham stimulationDevice

    The appearance is the same as the medical device for clinical trials, and when applied, the sound and the amount of light visible from the outside are designed to be the same as the medical device for clinical trials. The external light was the same, and only the high frequency that stimulates the dermis was blocked. The sham device was applied once a day for 30 minutes, a total of 3 times.

Study groups in NCT05185193
Study groupRoleWhat they receive
radiofrequency stimulationExperimentalParticipants received radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).
Receives: Device: radiofrequency
sham stimulationSham comparatorParticipants received a sham stimulation similar to a radiofrequency stimulation three times a day for 30 minutes once a day. After the end of the first session intervention, there was a washout period and the next intervention was started at a time point when the next menstruation was not likely (8-18 days after the onset of menstruation).
Receives: Device: sham stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Circumference(the lower calf at 7 cm proximal to the midpoint of the medial malleolus, behind the medial malleolus, and the dorsum of the foot)

    Circumference was measured using a tape measure at three anatomical locations.

    Measured: Changes of circumference before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

Secondary outcomes (4)
  1. Change of Volume

    The leg volume test is measured using Volumeters (Deluxe Foot) of Jeongdo BNP Co., Ltd. in Korea.

    Measure using the principle of overflowing, fill a cylinder with a diameter of 30cm and a height of 30cm with water, put one leg in the cylinder with the ankle bent at 90 degrees, and take the overflowing water and measure the amount in ml.

    Measured: Changes of volume before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  2. digital infrared thermal imaging(DITI)

    Measure the subject's leg body heat using DITI.

    Measured: Changes of body heat before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  3. Visual analog scale(VAS)

    Discomfort VAS is used to measure the degree of discomfort for lower extremity edema after application of the device. And 0 indicates no discomfort at all, and 10 indicates the most severe discomfort imaginable.

    Measured: Changes of VAS score before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

  4. weight

    Measure the participant's weight (kg) using a scale.

    Measured: Changes of weight before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2022
  2. Study start30 Jun 2020
  3. Primary completion21 Apr 2021
  4. Study completion21 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05185193
Sponsor's protocol ID
03-2020-001
Status last verified
Jan 2022
First submitted
9 Jun 2021
Last updated
11 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing radiofrequency in people with Idiopathic Edema, run by Pusan National University Yangsan Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Circumference(the lower calf at 7 cm proximal to the midpoint of the medial malleolus, behind the medial malleolus, and the dorsum of the foot) (time frame: Changes of circumference before and immediately after 30 minutes radiofrequency stimulation on once a day basis in the experimental group). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in